Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: Mifepristone (RU-486) in Androgen Independent Prostate Cancer [Phase 2]
Phase 2 trial of mifepristone (RU-486) in androgen-independent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating the combination of docetaxel and carboplatin in patients with hormone-refractory prostate cancer…
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer [Phase 2, Phase 3]
This document notes the completion of a Phase 2/3 clinical trial comparing celecoxib (Celebrex) to placebo in men with recurrent prostate ca…
-
CLINICAL_TRIALS research · 2009-12-09Clinical Trial Update: MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients [NA]
This document reports a completed clinical trial evaluating MRI-guided bone marrow biopsies in patients with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC] [Phase 2]
Phase 2 trial of weekly or every-3-week docetaxel plus prednisone in hormone-refractory prostate cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Docetaxel in the Treatment of Hormone Refractory Prostate Cancer [Phase 4]
A Phase 4 trial evaluating docetaxel for hormone-refractory prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2009-11-23Clinical Trial Update: Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis [Phase 4]
A Phase 4 open-label study assessed intravenous zoledronic acid 4 mg for effects on bone density in hormone-sensitive metastatic prostate ca…
-
CLINICAL_TRIALS other · 2009-11-23Clinical Trial Update: Maintaining Bone Strength in Men With Prostate Cancer [Phase 3]
A Phase 3 clinical trial investigating maintenance of bone strength in men with prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-11-23Clinical Trial Update: A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy [NA]
A completed clinical trial in prostate cancer sponsored by Novartis; the study under androgen deprivation therapy has finished.
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating the effect of octreotide acetate on circulating chromogranin A levels in patients with advanced prostate c…
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Exisulind Versus Placebo After Surgical Removal of the Prostate [Phase 2]
A Phase 2 randomized trial compared exisulind to placebo following surgical removal of the prostate to assess efficacy and safety in prostat…
-
CLINICAL_TRIALS other · 2009-11-03Clinical Trial Update: Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer [NA]
The document describes a clinical trial evaluating multifunctional Magnetic Resonance imaging to aid radiotherapy planning for prostate canc…
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients [NA]
This clinical trial update reports on how chemotherapy affects the uptake and retention of Carbon-11 methionine in patients with prostate ca…
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer [NA]
A completed clinical trial evaluating the correlation between C-11 acetate uptake and retention measured by PET in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2009-10-29Clinical Trial Update: An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy [Phase 2]
This document reports the completion of an open-label Phase IIa trial evaluating PRX302 for locally recurrent prostate cancer after primary …
-
CLINICAL_TRIALS research · 2009-10-19Clinical Trial Update: An Exploration of Genetic Testing for Prostate Cancer Susceptibility
This update describes a clinical study evaluating genetic testing to identify inherited susceptibility to prostate cancer. The sponsor is Ro…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Depiction of Prostate Cancer Treatment Alternatives in Greece
This clinical trial update notes that the study evaluating treatment alternatives for prostate cancer in Greece has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 1]
Phase 1 trial updates for an investigational monoclonal antibody therapy in patients with hormone-refractory prostate cancer.
-
CLINICAL_TRIALS trial_result · 2009-10-01Clinical Trial Update: Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer [Phase 2]
Phase II study of docetaxel plus celecoxib in patients with androgen-independent (metastatic) prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors [Phase 1]
Phase 1 trial comparing oral picoplatin with intravenous picoplatin in patients with solid tumors has been completed, evaluating safety and …
-
FDA approval · 2009-09-15FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for bicalutamide by Accord Healthcare Inc., authorizing changes to its approved labeling.
-
CLINICAL_TRIALS research · 2009-09-15Clinical Trial Update: Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment [Phase 1]
This entry describes a Phase 1 clinical trial evaluating focal therapy approaches for prostate cancer. The trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-08-17Clinical Trial Update: Far Infrared Radiation Treatment for Prostate Cancer [Phase 1]
This document reports a Phase 1 clinical trial update for far infrared radiation treatment in prostate cancer (prostatic neoplasms), sponsor…
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy [Phase 2]
A Phase 2 clinical trial evaluating oxygenation of the prostate gland in men undergoing prostate biopsy, which has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating fermented wheat germ extract (FWGE) in combination with hormone therapy for hormone-refractory prostate cancer; the…